A hopeful therapy for Niemann-Pick C diseases - The Lancet
Por um escritor misterioso
Descrição
Polyrotaxane-based systemic delivery of β-cyclodextrins for
Frontiers Advances in CRISPR/Cas gene therapy for inborn errors
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological
Experimental treatment for Niemann-Pick disease type C1 appears
Niemann–Pick disease, type C - Wikipedia
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological
Lysosomal storage diseases: Diagnostic confirmation and management
Advancements in Niemann-Pick Disease Type C Treatments
Lysosomal storage disorders: from biology to the clinic with
The complexity of a monogenic neurodegenerative disease: More than
Full article: Current advancements in therapy for Niemann-Pick
A Second Chance at Life”: Can Gene Therapies Beat Rare Disease
Current and Future Therapies for Hepatitis C Virus Infection
Lysosomal storage diseases—the horizon expands
A hopeful therapy for Niemann-Pick C diseases - The Lancet
de
por adulto (o preço varia de acordo com o tamanho do grupo)
